Ensuring Leadership Continuity—The Coleman Health Services Case Study is starting in

No National Rise In Buprenorphine Prescribing In First Year After Loosening Prescribing Rules

Between December 2022 and 2023, in the first year after the federal government loosened buprenorphine prescribing rules, the number of medical professionals able to prescribe buprenorphine increased 27%, from 42,158 in 2022 to 53,635 in December 2023. However, the number of people who filled buprenorphine prescriptions changed little after the rules were loosened in January 2023.

Previously, before they were allowed to prescribe buprenorphine, health care professionals were required to complete training to receive a special waiver (the x waiver) from the Drug Enforcement Administration (DEA) under the Drug Addiction Treatment Act (DATA). In addition to requiring training . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.